129 related articles for article (PubMed ID: 37909519)
21. Effects of cinnamon supplementation on expression of systemic inflammation factors, NF-kB and Sirtuin-1 (SIRT1) in type 2 diabetes: a randomized, double blind, and controlled clinical trial.
Davari M; Hashemi R; Mirmiran P; Hedayati M; Sahranavard S; Bahreini S; Tavakoly R; Talaei B
Nutr J; 2020 Jan; 19(1):1. PubMed ID: 31901246
[TBL] [Abstract][Full Text] [Related]
22. Cinnamon supplementation in patients with type 2 diabetes mellitus.
Pham AQ; Kourlas H; Pham DQ
Pharmacotherapy; 2007 Apr; 27(4):595-9. PubMed ID: 17381386
[TBL] [Abstract][Full Text] [Related]
23. Effects of Cinnamomum zeylanicum (Ceylon cinnamon) on blood glucose and lipids in a diabetic and healthy rat model.
Ranasinghe P; Perera S; Gunatilake M; Abeywardene E; Gunapala N; Premakumara S; Perera K; Lokuhetty D; Katulanda P
Pharmacognosy Res; 2012 Apr; 4(2):73-9. PubMed ID: 22518078
[TBL] [Abstract][Full Text] [Related]
24. The potential of cinnamon to reduce blood glucose levels in patients with type 2 diabetes and insulin resistance.
Kirkham S; Akilen R; Sharma S; Tsiami A
Diabetes Obes Metab; 2009 Dec; 11(12):1100-13. PubMed ID: 19930003
[TBL] [Abstract][Full Text] [Related]
25. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.
Derosa G; Cicero AF; Gaddi A; Ragonesi PD; Fogari E; Bertone G; Ciccarelli L; Piccinni MN
Clin Ther; 2004 May; 26(5):744-54. PubMed ID: 15220018
[TBL] [Abstract][Full Text] [Related]
26. The effect of cinnamon consumption on lipid profile, oxidative stress, and inflammation biomarkers in adults: An umbrella meta-analysis of randomized controlled trials.
Sarmadi B; Musazadeh V; Dehghan P; Karimi E
Nutr Metab Cardiovasc Dis; 2023 Oct; 33(10):1821-1835. PubMed ID: 37500345
[TBL] [Abstract][Full Text] [Related]
27. Effect of cinnamon on glucose control and lipid parameters.
Baker WL; Gutierrez-Williams G; White CM; Kluger J; Coleman CI
Diabetes Care; 2008 Jan; 31(1):41-3. PubMed ID: 17909085
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of 'true' cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: a systematic review and meta-analysis.
Ranasinghe P; Jayawardana R; Galappaththy P; Constantine GR; de Vas Gunawardana N; Katulanda P
Diabet Med; 2012 Dec; 29(12):1480-92. PubMed ID: 22671971
[TBL] [Abstract][Full Text] [Related]
29. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
[TBL] [Abstract][Full Text] [Related]
30. [Cinnamon: not suitable for the treatment of diabetes mellitus].
Kleefstra N; Logtenberg SJ; Houweling ST; Verhoeven S; Bilo HJ
Ned Tijdschr Geneeskd; 2007 Dec; 151(51):2833-7. PubMed ID: 18237052
[TBL] [Abstract][Full Text] [Related]
31. Effect of Aqueous Cinnamon Extract on the Postprandial Glycemia Levels in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial.
Rachid AP; Moncada M; Mesquita MF; Brito J; Bernardo MA; Silva ML
Nutrients; 2022 Apr; 14(8):. PubMed ID: 35458138
[TBL] [Abstract][Full Text] [Related]
32. Cinnamon in glycaemic control: Systematic review and meta analysis.
Akilen R; Tsiami A; Devendra D; Robinson N
Clin Nutr; 2012 Oct; 31(5):609-15. PubMed ID: 22579946
[TBL] [Abstract][Full Text] [Related]
33. Insulin resistance improvement by cinnamon powder in polycystic ovary syndrome: A randomized double-blind placebo controlled clinical trial.
Hajimonfarednejad M; Nimrouzi M; Heydari M; Zarshenas MM; Raee MJ; Jahromi BN
Phytother Res; 2018 Feb; 32(2):276-283. PubMed ID: 29250843
[TBL] [Abstract][Full Text] [Related]
34. Effect of short-term administration of cinnamon on blood pressure in patients with prediabetes and type 2 diabetes.
Akilen R; Pimlott Z; Tsiami A; Robinson N
Nutrition; 2013 Oct; 29(10):1192-6. PubMed ID: 23867208
[TBL] [Abstract][Full Text] [Related]
35. Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients.
Askari F; Rashidkhani B; Hekmatdoost A
Nutr Res; 2014 Feb; 34(2):143-8. PubMed ID: 24461315
[TBL] [Abstract][Full Text] [Related]
36. Is Cinnamon Efficacious for Glycaemic Control in Type-2 Diabetes Mellitus?
Sharma S; Mandal A; Kant R; Jachak S; Jagzape M
J Pak Med Assoc; 2020 Nov; 70(11):2065-2069. PubMed ID: 33341863
[TBL] [Abstract][Full Text] [Related]
37. Chromium and polyphenols from cinnamon improve insulin sensitivity.
Anderson RA
Proc Nutr Soc; 2008 Feb; 67(1):48-53. PubMed ID: 18234131
[TBL] [Abstract][Full Text] [Related]
38. Effects of Cinnamon Consumption on Glycemic Indicators, Advanced Glycation End Products, and Antioxidant Status in Type 2 Diabetic Patients.
Talaei B; Amouzegar A; Sahranavard S; Hedayati M; Mirmiran P; Azizi F
Nutrients; 2017 Sep; 9(9):. PubMed ID: 28885566
[TBL] [Abstract][Full Text] [Related]
39. The effect of hydroalcoholic Saffron (Crocus sativus L.) extract on fasting plasma glucose, HbA1c, lipid profile, liver, and renal function tests in patients with type 2 diabetes mellitus: A randomized double-blind clinical trial.
Moravej Aleali A; Amani R; Shahbazian H; Namjooyan F; Latifi SM; Cheraghian B
Phytother Res; 2019 Jun; 33(6):1648-1657. PubMed ID: 30942510
[TBL] [Abstract][Full Text] [Related]
40. Cinnamon intake lowers fasting blood glucose: meta-analysis.
Davis PA; Yokoyama W
J Med Food; 2011 Sep; 14(9):884-9. PubMed ID: 21480806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
